Amy Louise Brown
Guy's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Amy Louise Brown.
Cancer Prevention Research | 2013
Marcelo Sperandio; Amy Louise Brown; Claire Lock; Peter Morgan; Victoria Coupland; Peter Madden; Saman Warnakulasuriya; Henrik Møller
Dysplasia grading is widely used to assess risk of transformation in oral potentially malignant disorders despite limited data on predictive value. DNA ploidy analysis has been proposed as an alternative. This study examines the prognostic value for both tests used in a routine diagnostic setting to inform clinical management. A retrospective study of conventional dysplasia grading was conducted on 1,401 patients. DNA ploidy analysis was conducted on a subset of 273 patients and results correlated with clinical information, pathologic diagnosis, and outcome over 5 to 15 years. Malignant transformation occurred in 32 of 273 patients (12%) and, of these, 20 (63%) of preexisting index lesions were aneuploid. Of 241 patients not developing carcinoma, only 39 (16%) of index lesions were aneuploid. Epithelial dysplasia correlated with DNA ploidy status (P < 0.001). The overall positive predictive value for malignant transformation by DNA aneuploidy was 38.5% (sensitivity 65.2% and specificity 75%) and by severe dysplasia grade 39.5% (sensitivity 30% and specificity 98%). DNA diploid and tetraploid status had negative predictive value of 90% to 96%. Combining DNA ploidy analysis with dysplasia grading gives a higher predictive value than either technique alone. Each of three traditional dysplasia grades predicts a significantly different risk of carcinoma development and time to transformation. DNA ploidy analysis had equivalent predictive value and also detected additional risk lesions in the absence of dysplasia. Cancer Prev Res; 6(8); 822–31. ©2013 AACR.
Case Reports in Dentistry | 2015
Amy Louise Brown; Paulo Camargo de Moraes; Marcelo Sperandio; Andresa Borges Soares; Vera Cavalcanti de Araújo; Fabrício Passador-Santos
The peripheral giant cell granuloma (PGCG) is a nonneoplastic lesion commonly caused by local irritation. This report describes a 46-year-old Caucasian male who presented with a PGCG associated with a dental implant. The dental implant was originally placed in August 2012. Ten months later, the patient presented with a well-circumscribed lesion associated with and covering the implant, at which time the lesion was excised. Four months later, due to recurrence of the lesion, a deeper and wider excisional biopsy with curettage of the adjacent bone was performed. No evidence of recurrence has been reported after 12 months of follow-up. Immunohistochemistry, using the antibody CD68, was performed to investigate the origin of the multinucleated giant cells, with their immunophenotype being similar to those of other giant cell lesions, including central giant cell granuloma, foreign-body reactions, and granulomatous reactions to infectious agents.
Toxins | 2010
Peter G. Mantle; Cyrille Amerasinghe; Amy Louise Brown; Diana Herman; Thomas Horn; Thoger Krogh; Tomas Rosenbaum; Calin A. Tatu
DNA ploidy measurement has been applied uniquely to wax-embedded tissue of primary renal cell and metastatic tumours of a key experimental researcher on porcine ochratoxicosis, a control, and four transitional cell carcinomas from cases of Balkan endemic nephropathy. Primary renal tumour was diploid, and hyperdiploid metastasis was within the lower ploidy range for typical renal cell carcinoma. Three Balkan primary tumours showed extensive aneuploidy indicating marked nuclear instability, similar to model rat renal carcinoma caused by ochratoxin A. In contrast, much less nuclear instability in the putative occupational ochratoxicosis case fitted poorly with the ochratoxin A model.
Journal of Oral Pathology & Medicine | 2017
Victor Angelo Martins Montalli; Fabricio Passador-Santos; Elizabeth Ferreira Martinez; Cristiane Furuse; Maria Cássia Ferreira de Aguiar; Fernando Augusto Soares; Andresa Borges Soares; Amy Louise Brown; Ney Soares de Araújo; Vera Cavalcanti de Araújo
BACKGROUND Polymorphous low-grade adenocarcinoma (PLGA) remains a diagnostic challenge for most pathologists due to its large spectrum of histological patterns. In this study, the expression of two new markers recently described for salivary gland tumors was studied in PLGA. METHODS The morphology of 33 cases of PLGA was carefully evaluated using hematoxylin-and-eosin-stained sections and confirmed by immunohistochemistry for cytokeratin 7, vimentin, and S-100. Periodic acid-Schiff with diastase digestion was also used. The expression of mammaglobin and DOG-1 was carried out using the EnVision System. Mammaglobin was assessed according to the percentage of positively stained tumor cells, while DOG-1 was evaluated according to its presence and site. For MCM-2 and Ki-67, markers of proliferation, the labeling index of cell nuclei positivity was evaluated using total cell number. The ETV6-NTRK3 fusion was examined by fluorescence in situ hybridization analysis. RESULTS The histological patterns of the tumor were classified as lobular or non-lobular. For the non-lobular pattern, tubular, cribriform, glomeruliform, trabecular, and papillary patterns were observed. Mammaglobin was present in all PLGA cases, and its expression was stronger (P = 0.01) in the lobular than in the non-lobular pattern. The expression of DOG-1 was present in the apical portion and cytoplasm of the cells. Proliferation markers were low for all cases independent of histological pattern. CONCLUSIONS Polymorphous low-grade adenocarcinoma has been confirmed to originate from the intercalated duct and to feature high expression of mammaglobin in its lobular pattern resembling that of mammary secretory analogue carcinoma, except for the ETV6 gene rearrangement.
RGO - Revista Gaúcha de Odontologia | 2016
Mauro Antonio Dall Agnol; Amy Louise Brown; Luiz Alexandre Thomaz; José Luiz Cintra Junqueira; Luciana Butini Oliveira
A Sindrome de Goldenhar e rara e suas principais manifestacoes fisicas incluem assimetria e desenvolvimento facial incompleto, tumores dermoides epibulbares, malformacoes na orelha e apendices auriculares, anomalias vertebrais, disturbios no sistema nervoso central, irregularidades oculares e anomalias viscerais. A etiologia desta condicao nao e claramente esclarecida e apresenta-se geneticamente variavel. A incidencia da Sindrome de Goldenhar pode variar de 1:3500 ate 1:5600 nascidos vivos e relacao por sexo de 3:2 (masculino: feminino), apresentando mais frequentemente em criancas com surdez congenita. O objetivo deste trabalho e apresentar um caso clinico de Sindrome de Goldenhar em paciente infantil de 5 anos de idade do sexo masculino, sem historia familiar relevante relacionada a sindrome e que apresenta caracteristicas claras desta condicao. Considerando o envolvimento das estruturas craniofaciais da Sindrome de Goldenhar, sua raridade e o amplo espectro de sintomas e anormalidades sistemicas associadas, o conhecimento desta condicao e primordial para o cirurgiao-dentista.
Oral Oncology | 2007
P Klanrit; Marcelo Sperandio; Amy Louise Brown; P J Shirlaw; Stephen Challacombe; Peter Morgan
Oral Oncology | 2005
N Diwakar; Marcelo Sperandio; Martyn Sherriff; Amy Louise Brown
Experimental and Toxicologic Pathology | 2007
Amy Louise Brown; Peter G. Mantle
Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology | 2016
Marcelo Sperandio; Myriam F. Klinikowski; Amy Louise Brown; Penelope Shirlaw; Stephen Challacombe; Peter Morgan; Saman Warnakulasuriya
Tumor Biology | 2015
Natalia Festugatto Navarini; Vera Cavalcanti de Araújo; Amy Louise Brown; Fabrício Passador-Santos; Isabela Fernandes Souza; Marcelo Henrique Napimoga; Ney Soares de Araújo; Elizabeth Ferreira Martinez